References
- Hetlevik I. [The full bucket of general practice]. Tidsskr Nor Laegeforen 1999;119:3547–8.
- Getz L, Sigurdsson JA, Hetlevik I. Is opportunistic disease prevention in the consultation ethically justifiable? BMJ 2003;327:498–500.
- Sigurdsson JA, Getz L, Hetlevik I. [Check lists and screening – a threat against the consultation]. Lakartidningen 2004;101: 1412–15.
- Yarnall KSH, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: Is there enough time for prevention? Am J Public Health 2003;93:635–41.
- Nexoe J, Oltarzewska AM, Sawicka-Powierza J, Kragstrup J, Kristiansen IS. Perception of risk information: Similarities and differences between Danish and Polish general practitioners. Scand J Prim Health Care 2002;20:183–87.
- Phillips LS, Branch WT, Cook CB, Doyle JP, El Kebbi IM, Gallina DL . Clinical inertia. Ann Intern Med 2001;135:825–34.
- Graversen L, Christensen B, Borch-Johnsen K, Lauritzen T, Sandbaek A. General practitioners’ adherence to guidelines on mangement of dyslipidaemia: ADDITION-Denmark. Scand J Prim Health Care 2010;28:47–54.
- Welch HG, Schwartz L, Woloshin S. Overdiagnosed: Making people sick in the pursuit of health. Boston: Beacon Press; 2011.
- Getz L, Kirkengen AL, Hetlevik I, Romundstad S, Sigurdsson JA. Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice: A descriptive epidemiological study. Scand J Prim Health Care 2004;22:202–8.
- Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L . Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med 2000;132:769–79.
- Johannesson M. The cost-effectiveness of hypertension treatment in Sweden: An analysis of the criteria for intervention and the choice of drug treatment. J Hum Hypertens 1996;10(Suppl 2):S23–6.